ResearcherSichuan UniversityActive in the last 2 years
Yuncang Yuan
Matched on ORCID iD 0000-0002-2176-9674; OpenAlex author ID A5101895975. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 3
- Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models" [Translational Oncology volume… Co-author DOI 10.1016/j.tranon.2024.102252↗
- Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. Co-author DOI 10.1016/j.tranon.2023.101803↗
- GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. Co-author DOI 10.1186/s13045-023-01467-9↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xudong Zhao · 3 shared papers, 2023–2025 · strength 0.65
- Paper Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinica… DOI 10.1016/j.tranon.2024.102252↗
- Paper Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. DOI 10.1016/j.tranon.2023.101803↗
- Paper GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. DOI 10.1186/s13045-023-01467-9↗
- Yongjie Zhu · 2 shared papers, 2024–2025 · strength 0.47
- Paper Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinica… DOI 10.1016/j.tranon.2024.102252↗
- Paper Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. DOI 10.1016/j.tranon.2023.101803↗
- Xu Wei Luo · 2 shared papers, 2024–2025 · strength 0.47
- Paper Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinica… DOI 10.1016/j.tranon.2024.102252↗
- Paper Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. DOI 10.1016/j.tranon.2023.101803↗
- Jiawei Fan · 1 shared paper, 2023 · strength 0.18
- Bin Sun · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.